Table 4.
Univariable Analysis of Recurrence and Overall Survival
| Factor | P |
|---|---|
| Recurrence | |
| Patient variable | |
| Age | .849 |
| Sex | .111 |
| Ever-smoker | .950 |
| Comorbidities | |
| COPD | .609 |
| Hypertension | .729 |
| Diabetes mellitus | .734 |
| CAD | .082 |
| GERD | .159 |
| Previous cancer history | .165 |
| Pulmonary function (FEV1) | .606 |
| Operative variables | |
| Surgery | .391 |
| Laterality | .584 |
| Lobe involved | .067 |
| Operative time | .818 |
| Lymph nodes examined | .140 |
| Tumor size | .491 |
| Tumor histology | .881 |
| Overall survival | |
| Patient variables | |
| Age | < .001* |
| Sex | < .001* |
| Ever-smoker | .717 |
| Comorbidities | |
| COPD | .022* |
| Hypertension | .729 |
| Diabetes mellitus | .273 |
| CAD | .004* |
| GERD | .106 |
| Previous cancer history | .165 |
| Pulmonary function (FEV1) | .089 |
| Operative variables | |
| Surgery | .154 |
| Laterality | .986 |
| Lobe involved | .706 |
| Operative time | .143 |
| Tumor size | .008* |
| Tumor histology | .523 |
Abbreviations: CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; GERD, gastroesophageal reflux disease.
*
Statistically significant.